Deleterious mutations of SAMD9 are key enabling factors for some autoimmune diseases and cancers, as well as the pathogenesis of myelodysplastic syndromes (MDS), esophageal and lung tumorigenesis (29). This evidence concerns the gene SAMD9 and autoimmune disease.